Report Detail
(Post-pandemic Era)-Global Ion Channel Modulators Market Segment Research Report 2021
- RnM3867605 |
- 07 August, 2021 |
- Global |
- 96 Pages |
- XYZResearch |
- Machinery & Equipment
Summary
The global economy is expected to expand 5.6% in 2021，global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.
The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.
Regional Economic Prospects: Growth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.
The global Ion Channel Modulators market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to XYZResearch analysis, The segment in Ion Channel Modulators market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China Ion Channel Modulators production is XX (K Units). US market value in 2021 is about USD XX billion, and US Ion Channel Modulators production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe Ion Channel Modulators production is XX (K Units).
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Ion Channel Modulators Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Ion Channel Modulators Market?
Pfizer, Inc. (US)
Neusentis, Inc. (US)
AstraZeneca (UK)
Aurora Biomed, Inc. (Canada)
CalciMedica, Inc. (US)
Cellectricon AB (Sweden)
Convergence Pharmaceuticals Limited (UK)
Cytocentrics AG (Germany)
Evotec AG (Germany)
flyion GmbH (Germany)
GlaxoSmithKline Plc. (UK)
Nanion Technologies GmbH (Germany)
NeuroSearch A/S (Denmark)
Novartis AG (Switzerland)
Parion Sciences, Inc. (US)
Sanofi (France)
Targacept, Inc. (US)
Xention Limited (UK)
Zalicus, Inc. (US)
Major Type of Ion Channel Modulators Covered in XYZResearch report:
Channel Blockers
Channel Openers
Application Segments Covered in XYZResearch Market
Clinical Trials
Hospital
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Ion Channel Modulators Market Segment Research Report 2021
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global Ion Channel Modulators Market by Value
- 2.2.1 Global Ion Channel Modulators Revenue by Type
- 2.2.2 Global Ion Channel Modulators Market by Value (%)
- 2.3 Global Ion Channel Modulators Market by Production
- 2.3.1 Global Ion Channel Modulators Production by Type
- 2.3.2 Global Ion Channel Modulators Market by Production (%)
3. The Major Driver of Ion Channel Modulators Industry
- 3.1 Historical & Forecast Global Ion Channel Modulators Demand
- 3.2 Largest Application for Ion Channel Modulators (2017-2027)
- 3.3 The Major Downstream Company in China Market 2021
4. Global and Regional Ion Channel Modulators Market
- 4.1 Regional Market Size in Terms of Production & Demand (2021)
- 4.2 Regional Market Share in Terms of Revenue (2019-2027)
- 4.3 Concentration Ratio (CR5& CR10) of Ion Channel Modulators Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US Ion Channel Modulators Production, Demand (2017-2027)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
6. Europe Ion Channel Modulators Production, Demand (2017-2027)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
7. China Ion Channel Modulators Production, Demand (2017-2027)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
8. Japan Ion Channel Modulators Production, Demand (2017-2027)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
9. India Ion Channel Modulators Production, Demand (2017-2027)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
10. Korea Ion Channel Modulators Production, Demand (2017-2027)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
11. Southeast Asia Ion Channel Modulators Production, Demand (2017-2027)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
12. Global Ion Channel Modulators Average Price Trend
- 12.1 Market Price for Each Type of Ion Channel Modulators in US (2017-2021)
- 12.2 Market Price for Each Type of Ion Channel Modulators in Europe (2017-2021)
- 12.3 Market Price for Each Type of Ion Channel Modulators in China (2017-2021)
- 12.4 Market Price for Each Type of Ion Channel Modulators in Japan (2017-2021)
- 12.5 Market Price for Each Type of Ion Channel Modulators in India (2017-2021)
- 12.6 Market Price for Each Type of Ion Channel Modulators in Korea (2017-2021)
- 12.7 Market Price for Each Type of Ion Channel Modulators in Southeast Asia (2017-2021)
13. Industrial Chain (Impact of COVID-19)
- 13.1 Ion Channel Modulators Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Technology Trends of Ion Channel Modulators
14. Ion Channel Modulators Competitive Landscape
- 14.1 Pfizer, Inc. (US)
- 14.1.1 Pfizer, Inc. (US) Company Profiles
- 14.1.2 Pfizer, Inc. (US) Product Introduction
- 14.1.3 Pfizer, Inc. (US) Ion Channel Modulators Sales, Revenue (2017-2021)
- 14.1.4 Strategic initiatives
- 14.2 Neusentis, Inc. (US)
- 14.2.1 Neusentis, Inc. (US) Company Profiles
- 14.2.2 Neusentis, Inc. (US) Product Introduction
- 14.2.3 Neusentis, Inc. (US) Ion Channel Modulators Sales, Revenue (2017-2021)
- 14.2.4 Strategic initiatives
- 14.3 AstraZeneca (UK)
- 14.3.1 AstraZeneca (UK) Company Profiles
- 14.3.2 AstraZeneca (UK) Product Introduction
- 14.3.3 AstraZeneca (UK) Ion Channel Modulators Sales, Revenue (2017-2021)
- 14.3.4 Strategic initiatives
- 14.4 Aurora Biomed, Inc. (Canada)
- 14.4.1 Aurora Biomed, Inc. (Canada) Company Profiles
- 14.4.2 Aurora Biomed, Inc. (Canada) Product Introduction
- 14.4.3 Aurora Biomed, Inc. (Canada) Ion Channel Modulators Sales, Revenue (2017-2021)
- 14.4.4 Strategic initiatives
- 14.5 CalciMedica, Inc. (US)
- 14.5.1 CalciMedica, Inc. (US) Company Profiles
- 14.5.2 CalciMedica, Inc. (US) Product Introduction
- 14.5.3 CalciMedica, Inc. (US) Ion Channel Modulators Sales, Revenue (2017-2021)
- 14.5.4 Strategic initiatives
- 14.6 Cellectricon AB (Sweden)
- 14.6.1 Cellectricon AB (Sweden) Company Profiles
- 14.6.2 Cellectricon AB (Sweden) Product Introduction
- 14.6.3 Cellectricon AB (Sweden) Ion Channel Modulators Sales, Revenue (2017-2021)
- 14.6.4 Strategic initiatives
- 14.7 Convergence Pharmaceuticals Limited (UK)
- 14.7.1 Convergence Pharmaceuticals Limited (UK) Company Profiles
- 14.7.2 Convergence Pharmaceuticals Limited (UK) Product Introduction
- 14.7.3 Convergence Pharmaceuticals Limited (UK) Ion Channel Modulators Sales, Revenue (2017-2021)
- 14.7.4 Strategic initiatives
- 14.8 Cytocentrics AG (Germany)
- 14.8.1 Cytocentrics AG (Germany) Company Profiles
- 14.8.2 Cytocentrics AG (Germany) Product Introduction
- 14.8.3 Cytocentrics AG (Germany) Ion Channel Modulators Sales, Revenue (2017-2021)
- 14.8.4 Strategic initiatives
- 14.9 Evotec AG (Germany)
- 14.9.1 Evotec AG (Germany) Company Profiles
- 14.9.2 Evotec AG (Germany) Product Introduction
- 14.9.3 Evotec AG (Germany) Ion Channel Modulators Sales, Revenue (2017-2021)
- 14.9.4 Strategic initiatives
- 14.10 flyion GmbH (Germany)
- 14.10.1 flyion GmbH (Germany) Company Profiles
- 14.10.2 flyion GmbH (Germany) Product Introduction
- 14.10.3 flyion GmbH (Germany) Ion Channel Modulators Sales, Revenue (2017-2021)
- 14.10.4 Strategic initiatives
- 14.11 GlaxoSmithKline Plc. (UK)
- 14.12 Nanion Technologies GmbH (Germany)
- 14.13 NeuroSearch A/S (Denmark)
- 14.14 Novartis AG (Switzerland)
- 14.15 Parion Sciences, Inc. (US)
- 14.16 Sanofi (France)
- 14.17 Targacept, Inc. (US)
- 14.18 Xention Limited (UK)
- 14.19 Zalicus, Inc. (US)
15. Conclusion
Summary:
Get latest Market Research Reports on Ion Channel Modulators. Industry analysis & Market Report on Ion Channel Modulators is a syndicated market report, published as (Post-pandemic Era)-Global Ion Channel Modulators Market Segment Research Report 2021. It is complete Research Study and Industry Analysis of Ion Channel Modulators market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
